Skip to main content
Clinical Trials/JPRN-UMIN000030536
JPRN-UMIN000030536
Completed
Phase 2

A randomized Phase 2 study of the efficacy of cold therapy by using frozen gloves or compression therapy using surgical gloves on nab-paclitaxel induced peripheral neuropathy in breast cancer patients. - Prophylactic efficacy of frozen gloves or surgical gloves on nab-paclitaxel induced peripheral neuropathy.

Department of Outpatient Oncology Unit, Kyoto Prefectural University of Medicine0 sites34 target enrollmentDecember 24, 2017
ConditionsBreast Cancer

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
Department of Outpatient Oncology Unit, Kyoto Prefectural University of Medicine
Enrollment
34
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 24, 2017
End Date
March 31, 2019
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Department of Outpatient Oncology Unit, Kyoto Prefectural University of Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • With allergy for material of frozen globe and surgical glove Patients with neuropathic pain due to diseases such as diabetes and herpes zoster

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 2
A phase II study to evaluate the effectiveness of S-1 + Cetuximab for patients with advanced/recurrent colon cancer who cannot undergo intensive therapyadvanced/recurrent colon cancer patients with RAS wild-type tumors who cannot undergo intensive therapy
JPRN-UMIN000018484HO HOKKAIDO CANCER CENTER Division of Gastroenterology57
Active, not recruiting
Not Applicable
A phase II randomized study evaluating the role of 8 courses of primary chemotherapy versus 4 courses of primary chemotherapy in combination with endocrine therapy in locally advanced breast cancer. - NDlocally advanced breast cancerMedDRA version: 9.1Level: LLTClassification code 10057654Term: Breast cancer female
EUCTR2008-006383-10-ITISTITUTO EUROPEO DI ONCOLOGIA
Active, not recruiting
Not Applicable
A randomized phase II study to determine the efficacy and tolerability of two doses of eribulin plus lapatinib in trastuzumab pre-treated patients with HER2-positive metastatic breast cancer - E-VITAMETASTATIC BREAST CANCER in HER2 positiv PatientsMedDRA version: 14.1Level: PTClassification code 10055113Term: Breast cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2010-023237-37-DEGBG Forschungs GmbH (German Breast Group)80
Active, not recruiting
Not Applicable
A phase II study assessing the curative effect of the combination of lobectomy followed by mediastinal concomitant radiochemotherapy in patients with locally advanced unresectable stage III non-small cell lung cancer responding to induction chemotherapy.
EUCTR2006-004713-18-BEEuropean Lung Cancer Working Party75
Recruiting
Phase 2
A randomized phase II study to evaluate efficacy of negative pressure wound therapy on prophylaxis of the incisional hernia after reversal of temporaly diverting stomatemporally diverting stoma to be planned to have closed
JPRN-UMIN000030936Aichi Medical University70